GSK's experimental herpes vaccine fails to meet main goal in trial

[cafead]

via British drugmaker GSK (GSK.L) said on Wednesday its experimental herpes simplex virus (HSV) vaccine candidate failed to meet the main goal of a mid-stage trial and would not be taken forward to a late-stage trial.

article source